IN-VITRO STEPWISE SELECTION OF RESISTANCE TO QUINOLONES, BETA-LACTAMS AND AMIKACIN IN NOSOCOMIAL GRAM-NEGATIVE BACILLI

被引:20
|
作者
MICHEAHAMZEHPOUR, M [1 ]
KAHR, A [1 ]
PECHERE, JC [1 ]
机构
[1] UNIV GENEVA,CTR MED,DEPT GENET & MICROBIOL,CH-1211 GENEVA,SWITZERLAND
关键词
D O I
10.1007/BF01793574
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The ability of six antibiotics to produce resistance by stepwise selection on agar medium was assessed in 24 gram-negative rods. Escherichia coli was the strain least prone to selection of resistance, whereas Pseudomonas aeruginosa frequently developed resistance to all antibiotics. When used alone, ciprofloxacin, pefloxacin, amikacin, ceftazidime and cefpirome were associated with a comparable risk of acquired resistance (in 14 to 17 out of 24 strains); imipenem selected resistant strains in 10/24 isolates (5/18 in non-pseudomonas strains). The number of strains exhibiting cross resistance with structurally unrelated antibiotics was 11 after pefloxacin treatment, eight after exposure to ciprofloxacin, six after ceftazidime, and one after imipenem or cefpirome. The combination of ciprofloxacin with amikacin was less efficient in reducing acquisition of resistance than the combination of ciprofloxacin with a beta-lactam: ciprofloxacin plus cefpirome was especially potent in this respect.
引用
收藏
页码:S105 / S110
页数:6
相关论文
共 50 条
  • [21] In vitro synergistic activities of tobramycin and selected beta-lactams against 75 gram-negative clinical isolates
    Owens, RC
    Banevicius, MA
    Nicolau, DP
    Nightingale, CH
    Quintiliani, R
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) : 2586 - 2588
  • [22] CLINICAL EFFICACY OF INTRAVENOUS PUSH ADMINISTRATION OF BETA-LACTAMS IN GRAM-NEGATIVE BACTEREMIA
    Niss, Hannah
    Bennett, Nick
    Aragon, Laura
    Shemanski, Shelby
    Ploetz, Jeannette
    CRITICAL CARE MEDICINE, 2023, 51 (01) : 192 - 192
  • [23] BETA-LACTAMASE PRODUCTION AND SUSCEPTIBILITY OF UNITED-STATES AND EUROPEAN ANAEROBIC GRAM-NEGATIVE BACILLI TO BETA-LACTAMS AND OTHER AGENTS
    JACOBS, MR
    SPANGLER, SK
    APPELBAUM, PC
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1992, 11 (11) : 1081 - 1093
  • [24] ENDEMIC RESISTANCE TO AMIKACIN AMONG HOSPITAL ISOLATES OF GRAM-NEGATIVE BACILLI - IMPLICATIONS FOR THERAPY
    WORMSER, GP
    TATZ, J
    DONATH, J
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1983, 4 (02) : 93 - 99
  • [25] INVITRO INTERACTIONS OF AMIKACIN AND BETA-LACTAM ANTIBIOTICS AGAINST AMIKACIN-RESISTANT GRAM-NEGATIVE BACILLI
    ALVAREZ, S
    JONES, M
    HOLTSCLAWBERK, S
    BERK, SL
    CHEMOTHERAPY, 1988, 34 (02) : 107 - 112
  • [26] The Battle Is on: New Beta-Lactams for the Treatment of Multidrug-Resistant Gram-Negative Organisms
    Mandee Noval
    Mary Banoub
    Kimberly C. Claeys
    Emily Heil
    Current Infectious Disease Reports, 2020, 22
  • [27] The Battle Is on: New Beta-Lactams for the Treatment of Multidrug-Resistant Gram-Negative Organisms
    Noval, Mandee
    Banoub, Mary
    Claeys, Kimberly C.
    Heil, Emily
    CURRENT INFECTIOUS DISEASE REPORTS, 2020, 22 (01)
  • [28] The Effectiveness of Newer Beta-Lactams for the Treatment of Antimicrobial-Resistant Gram-Negative Meningitis
    Hsu, Alice J.
    Chiotos, Kathleen
    Heil, Emily L.
    Shields, Ryan K.
    Tamma, Pranita D.
    CLINICAL INFECTIOUS DISEASES, 2025,
  • [29] Antimicrobial resistance with focus on beta-lactam resistance in gram-negative bacilli
    Pitout, JDD
    Sanders, CC
    Sanders, WE
    AMERICAN JOURNAL OF MEDICINE, 1997, 103 (01) : 51 - 59
  • [30] Extended Spectrum Beta-lactamase Detection in Gram-negative Bacilli of Nosocomial Origin
    Tsering, Dechen C.
    Das, Shyamasree
    Adhiakari, Luna
    Pal, Ranabir
    Singh, Takhellambam S. K.
    JOURNAL OF GLOBAL INFECTIOUS DISEASES, 2009, 1 (02) : 87 - 92